Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Sarcoma 1Postoperative Complications 1Pain 1Ovarian Neoplasms 1Ovarian Cysts 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Advanced Ovarian Cancer 1

Interventions

Analgesia 4Psychiatric Rehabilitation 2Paclitaxel 2Fentanyl 2Behavior Therapy 2Zolpidem 1Uncertainty 1Taxes 1Sugars 1Ropivacaine 1Psychosocial Intervention 1Palliative Care 1Omacor 1Nutritional Support 1Naproxen 1Methods 1Massage 1Ketorolac Tromethamine 1Ketorolac 1Hydromorphone 1Glutathione 1Fish Oils 1Fatty Acids, Omega-3 1Early Intervention, Educational 1D-methadone 1Cognitive Behavioral Therapy 1Celecoxib 1Carboplatin 1Acupuncture Therapy 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × Ropivacaine × Gynecologic × Clear all
NCT00295945 2014-05-20

Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer

University of California, San Francisco

Completed
240 enrolled
GynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pain, Postoperative Complications, Sarcoma, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡